| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| b' Sevler Yildiz, Asl\\xc4\\xb1 Kaz\\xc4\\x9fan Kili\\xc3\\xa7aslan, Burcu Sirlier Emir, Kerim U\\xc4\\x9fur, Faruk Kili\\xc3\\xa. Serum HMGB1 and Beclin 1 Levels in Patients with a Diagnosis of Schizophrenia. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 35. issue 1. 2024-04-01. PMID:38556931.' |
in this study, we examined high mobility group box 1 protein (hmgb1) and beclin 1 levels and their relationship with clinical variables in patients with schizophrenia. |
2024-04-01 |
2024-04-03 |
Not clear |
| b' Sevler Yildiz, Asl\\xc4\\xb1 Kaz\\xc4\\x9fan Kili\\xc3\\xa7aslan, Burcu Sirlier Emir, Kerim U\\xc4\\x9fur, Faruk Kili\\xc3\\xa. Serum HMGB1 and Beclin 1 Levels in Patients with a Diagnosis of Schizophrenia. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 35. issue 1. 2024-04-01. PMID:38556931.' |
serum hmgb1 and beclin 1 levels in patients with a diagnosis of schizophrenia. |
2024-04-01 |
2024-04-03 |
Not clear |
| Michael Mackey, Laurena Holleran, Gary Donohoe, Declan P McKerna. Systematic Review and Meta-Analysis of Damage Associated Molecular Patterns HMGB1 and S100B in Schizophrenia. Psychiatry investigation. vol 21. issue 1. 2024-01-28. PMID:38281740. |
systematic review and meta-analysis of damage associated molecular patterns hmgb1 and s100b in schizophrenia. |
2024-01-28 |
2024-01-31 |
Not clear |
| Michael Mackey, Laurena Holleran, Gary Donohoe, Declan P McKerna. Systematic Review and Meta-Analysis of Damage Associated Molecular Patterns HMGB1 and S100B in Schizophrenia. Psychiatry investigation. vol 19. issue 12. 2023-01-02. PMID:36588432. |
systematic review and meta-analysis of damage associated molecular patterns hmgb1 and s100b in schizophrenia. |
2023-01-02 |
2023-08-14 |
Not clear |
| Song Chen, Mengzhuang Gou, Wenjin Chen, Meihong Xiu, Hongzhen Fan, Yunlong Tan, Li Tia. Alterations in innate immune defense distinguish first-episode schizophrenia patients from healthy controls. Frontiers in psychiatry. vol 13. 2022-10-31. PMID:36311523. |
the main purpose of this study was to evaluate whether circulating endotoxin, high mobility group box 1 protein (hmgb1) and complement component 4 (c4) could act as peripheral biomarkers to distinguish first-episode schizophrenia (fes, |
2022-10-31 |
2023-08-14 |
Not clear |
| Rana Fadhil Mousa, Hussein Kadhem Al-Hakeim, Amer Alhaideri, Michael Mae. Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral component of the phenome of schizophrenia: neuro-immune and opioid system correlates. Metabolic brain disease. vol 36. issue 1. 2021-10-07. PMID:32965599. |
we found that 45.1% of the variance in a latent vector extracted from cognitive test scores, schizophrenia symptoms and the ff score was explained by hmgb1, mor, em2, dkk1, and ccl11. |
2021-10-07 |
2023-08-13 |
Not clear |
| Elżbieta Kozłowska, Ewa Brzezińska-Błaszczyk, Justyna Agier, Adam Wysokiński, Paulina Żelechowsk. Alarmins (IL-33, sST2, HMGB1, and S100B) as potential biomarkers for schizophrenia. Journal of psychiatric research. vol 138. 2021-07-05. PMID:33957300. |
therefore, this study aimed to evaluate serum levels of the most promising alarmins (il-33, sst2, hmgb1, and s100b), as potent schizophrenia biomarkers. |
2021-07-05 |
2023-08-13 |
human |
| Elżbieta Kozłowska, Ewa Brzezińska-Błaszczyk, Justyna Agier, Adam Wysokiński, Paulina Żelechowsk. Alarmins (IL-33, sST2, HMGB1, and S100B) as potential biomarkers for schizophrenia. Journal of psychiatric research. vol 138. 2021-07-05. PMID:33957300. |
alarmins (il-33, sst2, hmgb1, and s100b) as potential biomarkers for schizophrenia. |
2021-07-05 |
2023-08-13 |
human |
| Elżbieta Kozłowska, Ewa Brzezińska-Błaszczyk, Justyna Agier, Adam Wysokiński, Paulina Żelechowsk. Alarmins (IL-33, sST2, HMGB1, and S100B) as potential biomarkers for schizophrenia. Journal of psychiatric research. vol 138. 2021-07-05. PMID:33957300. |
we documented that the serum levels of il-33 (p = 0.006), sst2 (p = 0.02), hmgb1 (p = 0.01), and s100b (p = 0.04) are significantly higher in patients with schizophrenia than in healthy subjects. |
2021-07-05 |
2023-08-13 |
human |
| Hussein Kadhem Al-Hakeim, Rana Fadhil Mousa, Arafat Hussein Al-Dujaili, Michael Mae. In schizophrenia, non-remitters and partial remitters to treatment with antipsychotics are qualitatively distinct classes with respect to neurocognitive deficits and neuro-immune biomarkers: results of soft independent modeling of class analogy. Metabolic brain disease. vol 36. issue 5. 2021-06-22. PMID:33580860. |
we recruited 60 nrtt, 50 prtt and 43 healthy controls and measured schizophrenia symptoms, neurocognitive tests, plasma ccl11, interleukin-(il)-6, il-10, dickkopf protein 1 (dkk1), high mobility group box-1 protein (hmgb1), κ- and μ-opioid receptors (kor and mor, respectively), endomorphin-2 (em-2), and β-endorphin. |
2021-06-22 |
2023-08-13 |
Not clear |